Hypoxia-inducible factor 1 alpha-mediated RelB/APOBEC3B down-regulation allows hepatitis B virus persistence
<p><strong>Background and Aims:</strong> Therapeutic strategies against HBV focus, among others, on the activation of the immune system to enable the infected host to eliminate HBV. Hypoxia‐inducible factor 1 alpha (HIF1α) stabilization has been associated with impaired immune resp...
Автори: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
Wolters Kluwer
2021
|